Hypoxia inducible factor as a therapeutic target for atherosclerosis.
Pharmacol Ther. 2018 Mar;183:22-33. doi: 10.1016/j.pharmthera.2017.09.003. Epub 2017 Sep 20.
Pharmacol Ther. 2018.
PMID: 28942242
Review.